News | November 10, 2022
AGC to establish Life Science Company in 2023
The Group will continue to make proactive investments of its management resources in the life science business
The Group will continue to make proactive investments of its management resources in the life science business
The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
The observations primarily relate to the need for improving strategies for microbial control, enhancing quality oversight, augmenting the use of software applications & computerized tools
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Multiples is the first private equity (PE) investor in the company
Subscribe To Our Newsletter & Stay Updated
